99mTc-hydroxymethane diphosphonate: a new bone imaging agent with a low tin content

Radiology. 1980 Jul;136(1):209-11. doi: 10.1148/radiology.136.1.6446106.

Abstract

A prospective double-blind comparison of 99mTc-hydroxymethane diphosphonate (HMDP) and 99mTc-methylene diphosphonate (MDP) as bone-seeking agents was performed with 102 patients. Densitometry showed that both cancellous/compact bone and cancellous bone/soft-tissue ratios were greater with HMDP (p less than 0.05); compact bone/soft-tissue and bone lesion/normal bone ratios were the same with both agents. Bone delineation, soft-tissue uptake, and overall image quality were the same with both agents. The HMDP formulation contained 78% fewer stannous ions and had a longer useful life after technetium labeling than MDP.

Publication types

  • Clinical Trial
  • Comparative Study
  • Controlled Clinical Trial

MeSH terms

  • Adolescent
  • Adult
  • Aged
  • Bone Neoplasms / diagnostic imaging
  • Bone and Bones / diagnostic imaging*
  • Child
  • Child, Preschool
  • Diphosphonates* / analysis
  • Double-Blind Method
  • Humans
  • Middle Aged
  • Radionuclide Imaging
  • Technetium Tc 99m Medronate
  • Technetium* / analysis
  • Tin / analysis*

Substances

  • Diphosphonates
  • technetium Tc 99m hydroxymethylene diphosphonate
  • Technetium
  • Tin
  • Technetium Tc 99m Medronate